Ligand Pharmaceuticals
LGND
#4264
Rank
NZ$4.67 B
Marketcap
NZ$385.47
Share price
-0.88%
Change (1 day)
109.74%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total assets

Total assets on the balance sheet as of December 2025 : NZ$2.64 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total assets are NZ$2.64 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Ligand Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31NZ$2.69 B61.37%
2024-12-31NZ$1.66 B34.15%
2023-12-31NZ$1.24 B3.63%
2022-12-31NZ$1.20 B-36.77%
2021-12-31NZ$1.89 B0.62%
2020-12-31NZ$1.88 B-14.94%
2019-12-31NZ$2.21 B18.09%
2018-12-31NZ$1.87 B98.94%
2017-12-31NZ$0.94 B8.79%
2016-12-31NZ$0.86 B18.16%
2015-12-31NZ$0.73 B123.19%
2014-12-31NZ$0.32 B158.44%
2013-12-31NZ$0.12 B0.54%
2012-12-31NZ$0.12 B-17.97%
2011-12-31NZ$0.15 B57.75%
2010-12-31NZ$97.93 M-49.84%
2009-12-31NZ$0.19 B-33.92%
2008-12-31NZ$0.29 B30.6%
2007-12-31NZ$0.22 B-51.12%
2006-12-31NZ$0.46 B0.55%
2005-12-31NZ$0.46 B-1.21%
2004-12-31NZ$0.46 B-3.56%
2003-12-31NZ$0.48 B-8.2%
2002-12-31NZ$0.52 B86.03%
2001-12-31NZ$0.28 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$337.62 B 12,664.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$352.78 B 13,238.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$190.62 B 7,107.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$153.52 B 5,704.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$33.98 B 1,185.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$231.96 B 8,669.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$152.59 B 5,669.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$139.49 B 5,174.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ$0.18 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA